“Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy”, Braz. J. Pharm. Sci., vol. 57, nov. 2022, doi: 10.1590/s2175-97902020000419078.